Insulin Delivery Devices Market 2021 Scope by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes), End User and Top Competitors - Becton, Dickinson and Company (U.S.), Novo

The Insulin Delivery Devices Market report is extremely valuable for mapping the strategies related to production, product launches, costing, inventory, purchasing, and marketing. This analysis provides an examination of various market segments that are relied upon to observe the fastest development amid the estimated forecast frame. All the data and information is very helpful to stay ahead of the competition when implemented in a correct manner. With the Insulin Delivery Devices Market business report it can also be analyzed that how the actions of key players are affecting the sales, import, export, revenue, and CAGR values. Market research offers actionable market insights which help create sustainable and money-spinning business strategies.

Request for FREE Sample Report: To Know the Impact of COVID-19 on this Industry @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=972929

Key players in the global insulin delivery devices market include

Becton, Dickinson and Company (U.S.),
Novo Nordisk A/S (Denmark),
Ypsomed Holding AG (Switzerland),
Medtronic plc (Ireland),
Animas Corporation (U.S.),
Tandem Diabetes Care, Inc. (U.S.),
Sanofi (France),
Biocon Ltd. (India),
Eli Lilly and Company (U.S.),
and Insulet Corporation (U.S.).

Favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, growing diabetic population, and rising awareness about insulin delivery devices are the major factors driving the growth of this market. However, needle anxiety ,emergence of oral drug delivery methods, and the growing trend of reuse of pen needles and infusion sets are the major factors restraining the growth of this market. Furthermore, increasing research and development activities and increasing diabetes-related health expenditure in emerging countries are likely to offer significant growth opportunities for players operating in the market.

The global insulin delivery devices market is segmented on the basis of type, end user, and region. In 2016, North America accounted for the largest share of the market, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region is projected to have the highest growth rate in the forecast period. Factors such as rising prevalence of diabetes, high adoption of insulin pens, and government initiatives in Singapore are expected to support the growth of the Asia-Pacific insulin delivery devices market.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, collaborations, agreements, partnerships, alliances, grants, joint ventures, acquisitions, and expansions) to increase their market shares and establish a strong foothold in the global market.

In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the insulin delivery devices market.

By Company Type: Tier 1: 70%, Tier 2: 22%, Tier 3: 8%
By Designation: Director Level: 65%, C-level: 25%, Others: 10%
By Region: North America: 55%, Europe: 20%, APAC: 20%, RoW: 5%

Research Coverage:

This report studies the insulin delivery devices market based on type, end-user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one, or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the types of insulin delivery devices offered by top players in the insulin delivery devices market
Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the insulin delivery devices market
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for insulin delivery devices across regions
Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the insulin delivery devices market
Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the insulin delivery devices market.

Enquire Here for, Report Enquiry, Discount and Customization @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=972929

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Insulin Delivery Devices: Market Snapshot
4.2 Geographic Analysis: Market, By Type (2016)
4.3 Insulin Delivery Devices Market Size, By End User, 2016 vs 2021 (USD Billion)
4.4 Geographic Snapshot of the Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Diabetic Population
5.2.1.2 Technological Advancements in Insulin Delivery Devices
5.2.1.3 Favorable Reimbursement Environment and Government Support in Selected Countries
5.2.1.4 Conferences, Meetings, and Congresses to Create Awareness About Insulin Delivery Devices
5.2.2 Restraints
5.2.2.1 Poor Reimbursement Structure in Developing Countries
5.2.2.2 Needle Anxiety in Patients to Affect the Growth of the Pen Needles and Syringes Market
5.2.2.3 Oral Insulin as an Alternative Drug Delivery Method
5.2.2.4 Issues Associated With the Reuse of Pen Needles and Infusion Sets
5.2.3 Opportunities
5.2.3.1 Increasing Research and Development Activities
5.2.3.2 Increasing Diabetes-Related Health Expenditure in Emerging Economies
5.2.3.3 Safety Needles
5.2.4 Challenge
5.2.4.1 Severe Shortage of Endocrinologists in the U.S.

6 Insulin Delivery Devices Market, By Type
6.1 Introduction
6.2 Pens
6.2.1 Reusable Insulin Pens
6.2.2 Disposable Insulin Pens
6.3 Insulin Pumps
6.3.1 External/Tethered Pumps
6.3.2 Patch Pumps
6.4 Pen Needles
6.4.1 Standard Pen Needles
6.4.2 Safety Pen Needles
6.5 Insulin Syringes
6.6 Other Insulin Delivery Devices

7 Insulin Delivery Devices Market, By End User
7.1 Introduction
7.2 Patients/Homecare
7.3 Hospitals & Clinics

8 Insulin Delivery Devices Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.1.1 Rising Prevalence of Diabetes and Favorable Reimbursement Scenario
8.2.1.2 Awareness Activities to Stimulate Usage of Insulin Delivery Devices in the U.S.
8.2.1.3 Growing Venture Capital Investments and Issuance of Ipos
8.2.1.4 FDA Approvals to Increase the Commercial Availability of Insulin Delivery Devices
8.2.2 Canada
8.2.2.1 High Prevalence of Diabetes and Favorable Reimbursement for Insulin Delivery Devices
8.2.2.2 Regulations for the Usage of Safety-Engineered Needles
8.3 Europe
8.3.1 Eu’s Directive on the Prevention of Sharps Injuries in Hospitals and the Healthcare Sector
8.3.2 Germany
8.3.2.1 High Prevalence of Diabetes, Favorable Reimbursement for Insulin Devices
8.3.3 France
8.3.3.1 High Insurance Coverage and Increasing Affordability
8.3.3.2 Conferences and Exhibitions
8.3.4 U.K.
8.3.4.1 Role of Diabetes U.K. in Research and Diabetes Care
8.3.4.2 Low Insulin Pump Penetration in the U.K.
8.3.5 Rest of Europe (RoE)
8.3.5.1 Spain: Regulations for Mandatory Use of Safety Needles, Large Diabetic Population
8.3.5.2 Italy: Regional Variations in Terms of Coverage and Benefits to Hinder Market Growth
8.3.5.3 Strong Presence of Major Insulin Delivery Device Manufacturers in RoE Countries
8.3.5.4 Large Diabetic Populations in Russia, Romania, Poland, and Portugal
8.4 Asia- Pacific
8.4.1 High Diabetes Incidence and Population in Asia-Pacific
8.4.2 Partnerships Among Global and Local Players in Asia-Pacific
8.4.3 Japan: High Adoption of Insulin Pens and Approval of Injectable Insulin
8.4.4 India: Low Penetration of Pen Needles & Pumps and Low Awareness to Restrain Market Growth
8.4.5 Government Initiatives in Singapore
8.4.6 Vietnam, A Potential Market for Insulin Delivery Devices
8.4.7 Australia: Amendments in Ndss to Broaden Patient Access to Diabetes Products
8.5 RoW
8.5.1 Increasing Diabetic Population
8.5.2 Rising Awareness on Diabetes
8.5.3 Conferences

9 Competitive Landscape
9.1 Overview
9.2 Market Share Analysis
9.3 Competitive Situation and Trends
9.3.1 Marketing and Promotion
9.3.2 Agreements, Alliances, Partnerships, Joint Ventures, and Collaborations
9.3.3 Product Launches
9.3.4 Expansions
9.3.5 Other Strategies

10 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
10.1 Introduction
10.2 Becton, Dickinson and Company
10.3 Novo Nordisk A/S
10.4 Medtronic PLC
10.5 Sanofi
10.6 ELI Lilly and Company
10.7 Ypsomed Holding AG
10.8 Animas Corporation (Johnson and Johnson)
10.9 Tandem Diabetes Care, Inc.
10.10 Insulet Corporation
10.11 Biocon Limited

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

11 Appendix
11.1 Discussion Guide
11.2 Other Developments
11.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
11.4 Introducing RT: Real-Time Market Intelligence
11.5 Available Customizations
11.6 Related Reports
11.7 Author Details

Purchase the Report Directly @ https://www.reportsnreports.com/purchase.aspx?name=972929

Contact Us:

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

This release was published on openPR.